`

Wednesday, 23 October 2019

Pharma/BioPharma News

  • Suven receives court approval to buy assets of Rising Pharmaceuticals

    Pharma/BioPharma |  News | 0 Comment | 15 Apr, 2019

    Suven Life Sciences Limited, a biopharmaceutical company provider of Contract Research and Manufacturing Services (CRAMS) for global life science companies, has received the US Bankruptcy C...Read more

  • Dr. Reddy's announces acquisition of ANDA portfolio

    Pharma/BioPharma |  News | 0 Comment | 15 Apr, 2019

    Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s” has entered into a definitive agreement to acquire a portfolio of 42...Read more

  • Wockhardt receives US FDA approval for cancer drug

    Pharma/BioPharma |  News | 0 Comment | 11 Apr, 2019

    Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for an ANDA for 50mg injection of Decitabine, whic...Read more

  • Vanta Bioscience signs Rs 29 Cr deal with Emcure Pharma

    Pharma/BioPharma |  News | 0 Comment | 09 Apr, 2019

    Vanta Bioscience Limited has announced that its step-down subsidiary ‘Vayam Research Solutions Limited’ has entered into a non-exclusive CRO Service Agreement with Emcure Pharma...Read more

  • Sun Pharma launches ready-to-infuse INFUGEM in the US

    Pharma/BioPharma |  News | 0 Comment | 08 Apr, 2019

    Sun Pharmaceutical Industries Ltd. has announced that INFUGEM™ (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the U.S. INFUGEM, the ...Read more

  • Everstone to sell controlling stake in Rubicon Research

    Pharma/BioPharma |  News | 0 Comment | 08 Apr, 2019

    Everstone is a premier investment group focused on India and South East Asia. Everstone Group’s Singapore fund, will sell its entire stake in Rubicon Research (Rubicon) to a global pr...Read more

  • Olon completes acquisition of Mahad plant

    Pharma/BioPharma |  News | 0 Comment | 08 Apr, 2019

    OlonS.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has announced the closing of the acquis...Read more

  • Lupin launches Tadalafil Tablets USP

    Pharma/BioPharma |  News | 0 Comment | 02 Apr, 2019

    Lupin has announced the launch of Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupi...Read more

  • Dr. Reddy’s announces US rights for its dermatology brands

    Pharma/BioPharma |  News | 0 Comment | 02 Apr, 2019

    Dr. Reddy’s Laboratories Limited, through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for SERNIVO® (betamethasone dipropionate) Spray, 0...Read more

  • Pulmatrix signs binding agreement with Cipla worth $22M

    Pharma/BioPharma |  News | 0 Comment | 02 Apr, 2019

    Pulmatrix, Inc., a clinical stage biopharmaceutical company focused on developing novel inhaled therapeutics to serve unmet needs in respiratory disease, has announced its entry into a Bind...Read more

  • Novartis to acquire IFM Tre in a $310M deal

    Pharma/BioPharma |  News | 0 Comment | 01 Apr, 2019

    IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, announced that it has reached a d...Read more

  • Lupin launches Fluocinonide Ointment USP 0.05%

    Pharma/BioPharma |  News | 0 Comment | 29 Mar, 2019

    Lupin announced the launch of Fluocinonide Ointment USP, 0.05%, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Fluocinonide Oi...Read more

  • Indian Pharma Sector: What Next After Gottlieb?

    Pharma/BioPharma |  News | 0 Comment | 29 Mar, 2019

    Indian drug makers, whose major part of business comes from the sale of generics in the US, received all the encouragement needed when the US Food and Drug Administration (USFDA) Commission...Read more

  • Jubilant Biosys adopts ForteBio's latest SPR System in India

    Pharma/BioPharma |  News | 0 Comment | 28 Mar, 2019

    Jubilant Biosys, a subsidiary of Jubilant Life Sciences Ltd has added advanced Pioneer FE system to its platform of drug discovery solutions available to customers. The Pioneer FE syst...Read more

  • Novartis’ Mayzent gets FDA nod to treat multiple sclerosis

    Pharma/BioPharma |  News | 0 Comment | 27 Mar, 2019

    Novartis has received the US Food and Drug Administration (FDA) approval of Mayzent® (siponimod) for the treatment of adults with relapsing forms of multiple sclerosis, including s...Read more

  • Alembic Pharma set to launch allergic conjunctivitis drug

    Pharma/BioPharma |  News | 0 Comment | 22 Mar, 2019

    Alembic Pharmaceuticals Limited has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Azelastine Hydrochloride Ophthalmic ...Read more

  • Syngene International wins CMO Leadership Awards

    Pharma/BioPharma |  News | 0 Comment | 22 Mar, 2019

    Syngene International Ltd., an innovation focused global discovery, development and manufacturing organization, announced that it has won the CMO Leadership Awards presented by Life Science...Read more

  • Pharmexcil to organize India Pavilion at Korea Pharm

    Pharma/BioPharma |  News | 0 Comment | 21 Mar, 2019

    Pharmaceuticals Export Promotion Council of India (Pharmexcil) is organizing India Pavilion at Korea Pharm, being held at Korea International Exhibition Center (KINTEX), Goyang, South Korea...Read more